RESEARCH - Possible treatment for PML in Tysabri MS patients under investigation

[Guest guest]

Possible Treatment For PML In Tysabri Multiple Sclerosis Partients

Under Investigation

MedicalNewsToday.com

Article Date: 29 Mar 2009 - 1:00 PDT

Helen Yates, Chief Executive of the Multiple Sclerosis Resource Centre

(MSRC) said: " We truly hope that the research leads to a treatment for

this very worrying and potentially life threatening condition. It is

important that people affected by MS that are undergoing treatment

with Tysabri have as much reassurance as possible about the potential

side effects and the ability to treat them should they arise. "

As reported by The Irish Times: A possible treatment for a potentially

fatal side effect of multiple sclerosis therapy, Tysabri, and other

immuno-modulating drugs is currently under investigation.

Biogen Idec, Elan's partner in the development and sale of Tysabri, is

testing the efficacy of a malaria pill developed during the Vietnam

war in treating progressive multifocal leukoencephalopathy (PML), the

brain infection that has been tied to use of Tysabri, according to Al

Sandrock, Biogen's head of neurology research.

******************************************

Read the full article here:

http://www.medicalnewstoday.com/articles/144008.php

Not an MD